Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-sulbactam (4:1) vs (2:1) Phase II study
CTR20130678Phase 2Suspended
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin + sulbactam in upper respiratory infection (URI), acute lower respiratory tract infection (LRTI), pneumonia, chronic bronchitis (CB), bronchiectasis. Started Oct 2013; status: suspended.
02
Drugs
amoxicillin + sulbactam
03
Conditions
upper respiratory infection (URI)acute lower respiratory tract infection (LRTI)pneumoniachronic bronchitis (CB)bronchiectasis
Beyond the preview
Go deeper on CTR20130678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130678.